DKSH has extended its strategic partnership with BUCHI, a leading manufacturer of laboratory equipment and solutions. DKSH will leverage its expertise and global experience to enhance BUCHI’s market presence in Australia.
Melbourne, Australia, July 19, 2024 – DKSH Australia Business Unit Technology has expanded its partnership with BUCHI, a leading provider of innovative technologies and laboratory products for research and development, quality control, and production facilities. DKSH will offer comprehensive sales, marketing, application support, and after-sales services in Australia, building on its successful partnership spanning over 10 years in the Philippines and Vietnam.
With a commitment to precision and reliability, BUCHI’s products support scientific advancements in chemistry, pharmaceuticals, food and beverage, environmental analysis, and beyond. Trusted worldwide, BUCHI continues to drive innovation in laboratory technology, empowering researchers and industry professionals to achieve excellence in their fields. DKSH, through this partnership, will focus on developing these technologies across all applicable industries including Research & Academia, Food and Feed, Pharmaceuticals, Environmental, Chemical, and more.
"BUCHI is delighted to partner with DKSH, building upon our successful relationships in Vietnam and the Philippines to now include Australia. With their proven track record and extensive experience, they are our ideal partner to expand in the Australian market. Together with DKSH, we are bringing cutting-edge technologies to our valued customers and ensuring they receive excellent support,” said John Chiu, General Manager at BUCHI.
Benoit Fissot, General Manager, Business Unit Technology, Australia and New Zealand, commented: “We are glad to have the opportunity to partner with BUCHI. This exclusive partnership enables DKSH to complete its product portfolio and introduce complete solutions to Australian customers. Leveraging our extensive sales coverage, application development capabilities, and unparalleled after-sales services, we will further grow BUCHI’s business in key market segments including Food and Feed and Environmental Solutions.”
About DKSH
For 80 years, BUCHI has been a leading solution provider in laboratory technology for R&D, quality control and production worldwide. The company is headquartered in Eastern Switzerland and has R&D, production, sales and service facilities around the world. BUCHI delivers efficient, high-quality solutions for the workup process in chemical and pharmaceutical research labs. The BUCHI Rotavapor is present in almost every R&D lab in the world and helps chemists to concentrate, dry and separate materials. In addition, our chromatography, freeze drying and spray drying solutions are essential for developing new drugs and compounds for the chemical industry. BUCHI is also a leader in food content analysis. Our Kjeldahl solutions enable the precise determination of protein content, whereas our extraction solutions are essential for determining fat content. BUCHI’s Near Infrared (NIR) Spectrometers provide a fast and simple way to determine many different parameters in the lab as well as in production. www.buchi.com
About DKSH
DKSH’s purpose is to enrich people’s lives. For almost 160 years, DKSH has been delivering growth for companies in Asia and beyond across its Business Units Healthcare, Consumer Goods, Performance Materials, and Technology. As a leading Market Expansion Services provider, DKSH offers sourcing, market insights, marketing and sales, eCommerce, distribution and logistics as well as after-sales services. DKSH is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. Listed on the SIX Swiss Exchange, DKSH operates in 36 markets with 29,040 specialists, generating net sales of CHF 11.1 billion in 2023. DKSH Business Unit Technology offers complete solutions for specialized scientific and industrial applications. With around 1,760 specialists, the Business Unit generated net sales of CHF 532.6 million in 2023. www.dksh.com/tec